<code id='197514D371'></code><style id='197514D371'></style>
    • <acronym id='197514D371'></acronym>
      <center id='197514D371'><center id='197514D371'><tfoot id='197514D371'></tfoot></center><abbr id='197514D371'><dir id='197514D371'><tfoot id='197514D371'></tfoot><noframes id='197514D371'>

    • <optgroup id='197514D371'><strike id='197514D371'><sup id='197514D371'></sup></strike><code id='197514D371'></code></optgroup>
        1. <b id='197514D371'><label id='197514D371'><select id='197514D371'><dt id='197514D371'><span id='197514D371'></span></dt></select></label></b><u id='197514D371'></u>
          <i id='197514D371'><strike id='197514D371'><tt id='197514D371'><pre id='197514D371'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:115
          STAT's Megan Molteni speaks with Feng Zhang in New York on March 21, 2024
          Scientist Feng Zhang, right, is interviewed by reporter Megan Molteni at STAT's Breakthrough Summit East. STAT

          When the first biotech companies emerged to capitalize on the revolutionary genome-editing technology CRISPR, Editas Medicine seemed like the pacesetter. It locked up some of the crucial IP, and had behind it the pioneering scientist Feng Zhang of the Broad Institute as one of its founders.

          But now, a decade later, Editas is seen as lagging behind its peers. CRISPR Therapeutics, in partnership with Vertex Pharmaceuticals, won the race to get the first CRISPR-based medicine across the finish line. Intellia Therapeutics was the first to show that CRISPR editing could be performed inside the body. Editas, meanwhile, has seen a revolving door among its executives.

          advertisement

          So what happened?

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more
          Biogen shutters digital health group, ends Apple study, in cost cutting move
          Biogen shutters digital health group, ends Apple study, in cost cutting move

          RubyWallauforSTATBiogen,theiconicbutembattledbiotechfirm,isshutteringBiogenDigitalHealth,itsroughly1

          read more
          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more

          iTeos Therapeutics debuts first data on TIGIT

          AdobeITeosTherapeuticsofferedthefirstlookatclinicaldataforitsexperimentalcancerantibodythatworksbybl